These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30470547)

  • 1. Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development.
    Tom JK; Albin TJ; Manna S; Moser BA; Steinhardt RC; Esser-Kahn AP
    Trends Biotechnol; 2019 Apr; 37(4):373-388. PubMed ID: 30470547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The path forward.
    De Gregorio E
    Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New generation adjuvants--from empiricism to rational design.
    O'Hagan DT; Fox CB
    Vaccine; 2015 Jun; 33 Suppl 2():B14-20. PubMed ID: 26022561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland.
    Collin N
    Hum Vaccin Immunother; 2013 Sep; 9(9):2015-6. PubMed ID: 23966098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaps in knowledge and prospects for research of adjuvanted vaccines.
    Seder R; Reed SG; O'Hagan D; Malyala P; D'Oro U; Laera D; Abrignani S; Cerundolo V; Steinman L; Bertholet S
    Vaccine; 2015 Jun; 33 Suppl 2():B40-3. PubMed ID: 26022566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging concepts in the science of vaccine adjuvants.
    Pulendran B; S Arunachalam P; O'Hagan DT
    Nat Rev Drug Discov; 2021 Jun; 20(6):454-475. PubMed ID: 33824489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern Vaccine Adjuvant/Formulation--Session 9: Adjuvants.
    Dalençon F
    Hum Vaccin Immunother; 2013 Sep; 9(9):2013-4. PubMed ID: 23938771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are we entering a new age for human vaccine adjuvants?
    O'Hagan DT; Fox CB
    Expert Rev Vaccines; 2015 Jul; 14(7):909-11. PubMed ID: 25947042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine adjuvants: scientific challenges and strategic initiatives.
    Harandi AM; Davies G; Olesen OF
    Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From discovery to licensure, the Adjuvant System story.
    Garçon N; Di Pasquale A
    Hum Vaccin Immunother; 2017 Jan; 13(1):19-33. PubMed ID: 27636098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis driven development of new adjuvants: short peptides as immunomodulators.
    Dong JC; Kobinger GP
    Hum Vaccin Immunother; 2013 Apr; 9(4):808-11. PubMed ID: 23563510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical and functional characterization of vaccine antigens and adjuvants.
    Dey AK; Malyala P; Singh M
    Expert Rev Vaccines; 2014 May; 13(5):671-85. PubMed ID: 24702271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourth International Conference: Modern Vaccines/Adjuvants Formulation--Impact on Future Development: May 15-17 2013, CHUV, Lausanne, Switzerland.
    Tupin E
    Hum Vaccin Immunother; 2013 Sep; 9(9):2009-12. PubMed ID: 23896583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in adjuvant discovery for peptide-based subunit vaccines.
    Azmi F; Ahmad Fuaad AA; Skwarczynski M; Toth I
    Hum Vaccin Immunother; 2014; 10(3):778-96. PubMed ID: 24300669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination adjuvants: the next generation of adjuvants?
    Mutwiri G; Gerdts V; van Drunen Littel-van den Hurk S; Auray G; Eng N; Garlapati S; Babiuk LA; Potter A
    Expert Rev Vaccines; 2011 Jan; 10(1):95-107. PubMed ID: 21162624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant system AS01: helping to overcome the challenges of modern vaccines.
    Didierlaurent AM; Laupèze B; Di Pasquale A; Hergli N; Collignon C; Garçon N
    Expert Rev Vaccines; 2017 Jan; 16(1):55-63. PubMed ID: 27448771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of databases, data mining and immunoinformatics in vaccinology: where are we?
    Hegde NR; Gauthami S; Sampath Kumar HM; Bayry J
    Expert Opin Drug Discov; 2018 Feb; 13(2):117-130. PubMed ID: 29226722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of vaccine adjuvants.
    Ribeiro CM; Schijns VE
    Methods Mol Biol; 2010; 626():1-14. PubMed ID: 20099117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.